Pierre Fabre, XtalPi Partner on AI Drug Discovery
Laboratoires Pierre Fabre and XtalPi have entered a drug discovery collaboration that combines artificial intelligence, robotics and pharmaceutical R&D expertise to develop novel small-molecule clinical candidates. The multi-program agreement will initially focus on oncology, with potential applications in dermatology and rare diseases, targeting areas that have historically proved difficult for conventional drug discovery approaches. The…
